Glycaemic efficacy and safety of linagliptin for the management of non-cardiac surgery patients with type 2 diabetes in a real-world setting: Lina-Surg study

A Randomized Controlled Trial on the Safety and Efficacy of Exenatide Therapy for the Inpatient Management of General Medicine and Surgery Patients With Type 2 Diabetes

(2019) Maya Fayfman et al.   DIABETES CARE

National trends in diabetes mellitus hospitalization in Spain 1997–2010: Analysis of over 5.4 millions of admissions

(2018) Carmen M. Lara-Rojas et al.   European Journal of Internal Medicine

Use of Linagliptin for the Management of Medicine Department Inpatients with Type 2 Diabetes in Real-World Clinical Practice (Lina-Real-World Study)

(2018) Luis Pérez-Belmonte et al.   Journal of Clinical Medicine

9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2019

(2018)   DIABETES CARE

15. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes—2019

(2018)   DIABETES CARE

Glycaemic efficacy and safety of linagliptin compared to a basal-bolus insulin regimen in patients with type 2 diabetes undergoing non-cardiac surgery: A multicentre randomized clinical trial

(2018) Priyathama Vellanki et al.   DIABETES OBESITY & METABOLISM

Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk

(2018) Julio Rosenstock et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Sitagliptin plus basal insulin: simplifying in-hospital diabetes treatment?

(2017) Michael A Nauck et al.   Lancet Diabetes & Endocrinology

Efficacy of sitagliptin for the hospital management of general medicine and surgery patients with type 2 diabetes (Sita-Hospital): a multicentre, prospective, open-label, non-inferiority randomised trial

(2017) Francisco J Pasquel et al.   Lancet Diabetes & Endocrinology

Efficacy and Cardiovascular Safety of Linagliptin as an Add-On to Insulin in Type 2 Diabetes: A Pooled Comprehensive Post Hoc Analysis

(2016) Bernard Zinman et al.   Canadian Journal of Diabetes

Diabetic emergencies — ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia

(2016) Guillermo Umpierrez et al.   Nature Reviews Endocrinology

Predictive Value of Admission Hemoglobin A1con Inpatient Glycemic Control and Response to Insulin Therapy in Medicine and Surgery Patients With Type 2 Diabetes: Table 1

(2015) Francisco J. Pasquel et al.   DIABETES CARE

Is Incretin-Based Therapy Ready for the Care of Hospitalized Patients With Type 2 Diabetes?: Insulin therapy has proven itself and is considered the mainstay of treatment

(2013) G. E. Umpierrez et al.   DIABETES CARE

Safety and Efficacy of Sitagliptin Therapy for the Inpatient Management of General Medicine and Surgery Patients With Type 2 Diabetes: A pilot, randomized, controlled study

(2013) G. E. Umpierrez et al.   DIABETES CARE

Management of Hyperglycemia in Hospitalized Patients in Non-Critical Care Setting: An Endocrine Society Clinical Practice Guideline

(2012) Guillermo E. Umpierrez et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Hypoglycemia-associated Mortality Is Not Drug-associated but Linked to Comorbidities

(2011) Laura Boucai et al.   AMERICAN JOURNAL OF MEDICINE

Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes Undergoing General Surgery (RABBIT 2 Surgery)

(2011) G. E. Umpierrez et al.   DIABETES CARE

Linagliptin, a xanthine-based dipeptidyl peptidase-4 inhibitor with an unusual profile for the treatment of type 2 diabetes

(2009) Carolyn F Deacon et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Comparison of Inpatient Insulin Regimens with Detemir plus AspartVersusNeutral Protamine Hagedorn plus Regular in Medical Patients with Type 2 Diabetes

(2008) Guillermo E. Umpierrez et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Diabetes Management in the Hospital

(2008) Thomas W. Donner et al.   MEDICAL CLINICS OF NORTH AMERICA